Skip to content
PICO Portalanswers from OpenAlex

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection

PaperCitations, authors & open-access status

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection is a paper indexed in PICO Portal from OpenAlex.

How many citations does Antitumor activity of nivolumab on hemodialysis after renal allograft rejection have?

PICO Portalcitation count

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection has 81 citations in the OpenAlex counts PICO Portal stores.

When was Antitumor activity of nivolumab on hemodialysis after renal allograft rejection published?

PICO Portalyear

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection has 2016 year in the PICO Portal index.

What is the open-access status of Antitumor activity of nivolumab on hemodialysis after renal allograft rejection?

PICO Portaloa status

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection has gold oa status in the PICO Portal index.

What is the DOI of Antitumor activity of nivolumab on hemodialysis after renal allograft rejection?

PICO Portaldoi

The DOI for Antitumor activity of nivolumab on hemodialysis after renal allograft rejection is on the source record.

What is the PMID of Antitumor activity of nivolumab on hemodialysis after renal allograft rejection?

PICO Portalpmid

The PMID for Antitumor activity of nivolumab on hemodialysis after renal allograft rejection is on the source record.

What is the OpenAlex record for Antitumor activity of nivolumab on hemodialysis after renal allograft rejection?

PICO Portalopenalex

The OpenAlex for Antitumor activity of nivolumab on hemodialysis after renal allograft rejection is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial